Ark Biosci 
Welcome,         Profile    Billing    Logout  
 2 Products   0 Diseases  2 Products   5 Trials   35 News 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Azstarys (serdexmethylphenidate/dexmethylphenidate oral) / Corium
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

Completed
4
246
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac
Attention Deficit/Hyperactivity Disorder
05/24
05/24
NCT06000501: Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening

Completed
4
29
US
Serdexmethylphenidate/dexmethylphenidate, Azstarys
NYU Langone Health, Corium, Inc.
Adult Attention Deficit Hyperactivity Disorder
07/24
07/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Active, not recruiting
4
123
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials
Attention Deficit/Hyperactivity Disorder
07/25
07/25
NCT06359899: A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD

Not yet recruiting
3
50
RoW
AK0901 capsule, AZSTARYS (SDX/d-MPH capsules), Placebo
Shanghai Ark Biopharmaceutical Co., Ltd.
ADHD
09/24
10/24
ziresovir (AK0529) / Ark Biosci
AK0529-2007, NCT06775405: A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Recruiting
3
180
RoW
AK0529, Placebo
Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory Synctial Virus Infections
08/25
09/25
NCT06942299: A Study of AK0529 in Adults Patients Hospitalized With RSV Infection

Completed
2
25
RoW
AK0529, Placebo
Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory Syncytial Virus Infections
06/24
06/24
NCT06591845: Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

Not yet recruiting
1
32
NA
Ziresovir 125 mg, Ziresovir 500 mg, Placebo, Moxifloxacin hydrochloride tablet 400 mg
Shanghai Ark Biopharmaceutical Co., Ltd.
Healthy Volunteers
12/24
12/24
AK3280 / Ark Biosci
AK3280-2002, NCT05424887: A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Not yet recruiting
2
105
RoW
AK3280, Placebo
Ark Biosciences Inc., Shanghai Ark Biopharmaceutical Co., Ltd.
Idiopathic Pulmonary Fibrosis
07/24
10/24
NCT05434897: A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Not yet recruiting
1/2
30
RoW
AK3280 Cream, AK3287, Placebo cream
Ark Biosciences Inc., Shanghai Ark Biopharmaceutical Co., Ltd.
Hypertrophic Scar
07/23
11/23
AK0705 / Ark Biosci, Scripps Research Institute
No trials found
AK0706 / Ark Biosci
No trials found
AK0605 / Ark Biosci
No trials found
AK0701 / Ark Biosci
No trials found
AK0707 / Ark Biosci
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Azstarys (serdexmethylphenidate/dexmethylphenidate oral) / Corium
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

Completed
4
246
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac
Attention Deficit/Hyperactivity Disorder
05/24
05/24
NCT06000501: Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening

Completed
4
29
US
Serdexmethylphenidate/dexmethylphenidate, Azstarys
NYU Langone Health, Corium, Inc.
Adult Attention Deficit Hyperactivity Disorder
07/24
07/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Active, not recruiting
4
123
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials
Attention Deficit/Hyperactivity Disorder
07/25
07/25
NCT06359899: A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD

Not yet recruiting
3
50
RoW
AK0901 capsule, AZSTARYS (SDX/d-MPH capsules), Placebo
Shanghai Ark Biopharmaceutical Co., Ltd.
ADHD
09/24
10/24
ziresovir (AK0529) / Ark Biosci
AK0529-2007, NCT06775405: A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Recruiting
3
180
RoW
AK0529, Placebo
Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory Synctial Virus Infections
08/25
09/25
NCT06942299: A Study of AK0529 in Adults Patients Hospitalized With RSV Infection

Completed
2
25
RoW
AK0529, Placebo
Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory Syncytial Virus Infections
06/24
06/24
NCT06591845: Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

Not yet recruiting
1
32
NA
Ziresovir 125 mg, Ziresovir 500 mg, Placebo, Moxifloxacin hydrochloride tablet 400 mg
Shanghai Ark Biopharmaceutical Co., Ltd.
Healthy Volunteers
12/24
12/24
AK3280 / Ark Biosci
AK3280-2002, NCT05424887: A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Not yet recruiting
2
105
RoW
AK3280, Placebo
Ark Biosciences Inc., Shanghai Ark Biopharmaceutical Co., Ltd.
Idiopathic Pulmonary Fibrosis
07/24
10/24
NCT05434897: A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Not yet recruiting
1/2
30
RoW
AK3280 Cream, AK3287, Placebo cream
Ark Biosciences Inc., Shanghai Ark Biopharmaceutical Co., Ltd.
Hypertrophic Scar
07/23
11/23
AK0705 / Ark Biosci, Scripps Research Institute
No trials found
AK0706 / Ark Biosci
No trials found
AK0605 / Ark Biosci
No trials found
AK0701 / Ark Biosci
No trials found
AK0707 / Ark Biosci
No trials found

Download Options